4.7 Article

Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes

Journal

DIABETOLOGIA
Volume 62, Issue 7, Pages 1268-1274

Publisher

SPRINGER
DOI: 10.1007/s00125-019-4883-4

Keywords

Diabetic nephropathy; End-stage renal disease; Soluble receptor for advanced glycation end-products; Type 1 diabetes

Funding

  1. Folkhalsan Research Foundation
  2. Wilhelm and Else Stockmann Foundation
  3. Waldemar von Frenckell Foundation
  4. Liv och Halsa Foundation
  5. Novo Nordisk Foundation
  6. Maud Kuistila Foundation
  7. Emil Aaltonen Foundation
  8. Academy of Finland

Ask authors/readers for more resources

Aims/hypothesis Activation of the receptor for AGE (RAGE) has been shown to be associated with diabetic nephropathy. The soluble isoform of RAGE (sRAGE) is considered to function as a decoy receptor for RAGE ligands and thereby protects against diabetic complications. A possible association between sRAGE and diabetic nephropathy is still, however, controversial and a more comprehensive analysis of sRAGE with respect to diabetic nephropathy in type 1 diabetes is therefore warranted. Methods sRAGE was measured in baseline serum samples from 3647 participants with type 1 diabetes from the nationwide multicentre Finnish Diabetic Nephropathy (FinnDiane) Study. Associations between sRAGE and diabetic nephropathy, as well as sRAGE and diabetic nephropathy progression, were evaluated by regression, competing risks and receiver operating characteristic curve analyses. The non-synonymous SNP rs2070600 (G82S) was used to test causality in the Mendelian randomisation analysis. Results Baseline sRAGE concentrations were highest in participants with diabetic nephropathy, compared with participants with a normal AER or those with microalbuminuria. Baseline sRAGE was associated with progression from macroalbuminuria to end-stage renal disease (ESRD) in the competing risks analyses, but this association disappeared when eGFR was entered into the model. The SNP rs2070600 was strongly associated with sRAGE concentrations and with progression from macroalbuminuria to ESRD. However, Mendelian randomisation analysis did not support a causal role for sRAGE in progression to ESRD. Conclusions/interpretations RAGE is associated with progression from macroalbuminuria to ESRD, but does not add predictive value on top of conventional risk factors. Although sRAGE is a biomarker of diabetic nephropathy, in light of the Mendelian randomisation analysis it does not seem to be causally related to progression from macroalbuminuria to ESRD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Endocrinology & Metabolism

Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes

Erika B. Parente, Stefan Mutter, Lena M. Thorn, Valma Harjutsalo, Per-Henrik Groop

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease

Patrik Smidtslund, Fanny Jansson Sigfrids, Anni Ylinen, Nina Elonen, Valma Harjutsalo, Per-Henrik Groop, Lena M. Thorn

Summary: This study aims to investigate the prognosis after a first-ever myocardial infarction (MI) in individuals with type 1 diabetes and how different MI- and diabetes-related factors affect the prognosis and risk of secondary cardiovascular events. The study found that individuals with type 1 diabetes have a high cardiovascular and diabetes-related mortality after their first-ever MI, and poor kidney function is associated with high mortality and excessive risk of secondary cardiovascular events.

DIABETES CARE (2023)

Article Clinical Neurology

Long-term favorable prognosis in late onset dominant distal titinopathy: Tibial muscular dystrophy

Victoria Lillback, Marco Savarese, Niina Sandholm, Peter Hackman, Bjarne Udd

Summary: In this retrospective study, the disease progression of 137 TMD patients over 15 years was observed. The main symptoms of TMD patients were walking difficulties and weakness in distal lower limbs. The progression of the weakness was moderate and cardiomyopathy was not developed due to the titin defect alone. These findings provide important information for the accurate identification and therapeutic intervention of TMD.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Cardiac & Cardiovascular Systems

Higher HbA1c variability is associated with increased arterial stiffness in individuals with type 1 diabetes

Anniina Tynjala, Valma Harjutsalo, Fanny Jansson Sigfrids, Per-Henrik Groop, Daniel Gordin

Summary: This study investigated the association between long-term glycemic variability and arterial stiffness in patients with type 1 diabetes. The results showed that the variability of HbA1c was significantly correlated with arterial stiffness. Importantly, this association was independent of the HbA1c mean.

CARDIOVASCULAR DIABETOLOGY (2023)

Article Clinical Neurology

Delayed bedtime on non-school days associates with higher weight and waist circumference in children: Cross-sectional and longitudinal analyses with Mendelian randomisation

Heli Viljakainen, Elina Engberg, Emma Dahlstrom, Sohvi Lommi, Jari Lahti

Summary: Sleep duration has been associated with obesity, especially bedtime discrepancy between school and non-school days in children. Later bedtime on non-school nights and delay in bedtime compared with school nights are associated with higher BMIz and WtHr, also predicting higher WtHr longitudinally. Promoting early bedtimes, especially on weekends, should be considered to prevent obesity in school-aged children.

JOURNAL OF SLEEP RESEARCH (2023)

Article Endocrinology & Metabolism

Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses

Minna Harsunen, Jani Haukka, Valma Harjutsalo, Nina Mars, Anna Syreeni, Taina Harkonen, Annemari Karajaemaki, Jorma Ilonen, Mikael Knip, Niina Sandholm, Paivi Johanna Miettinen, Per-Henrik Groop, Tiinamaija Tuomi

Summary: Contrary to the presumption that type 1 diabetes leads to an absolute insulin deficiency, this study found that many individuals with type 1 diabetes still have circulating C-peptide years after diagnosis. The study also identified the correlation between age at diagnosis and decline in C-peptide secretion, as well as the association between polygenic risk scores, clinical factors, and random serum C-peptide concentrations.

LANCET DIABETES & ENDOCRINOLOGY (2023)

Review Endocrinology & Metabolism

Genetic and epigenetic background of diabetic kidney disease

Niina Sandholm, Emma H. Dahlstrom, Per-Henrik Groop

Summary: Diabetic kidney disease (DKD) is a severe complication of diabetes, affecting a significant portion of patients. While elevated blood glucose levels play a key role in DKD, it is a complex disease with both genetic and environmental factors contributing to its development. Genome-wide association studies (GWASs) have been valuable in identifying genetic risk factors for DKD, and recent advancements in sequencing techniques have allowed for the discovery of rare genetic variants. Epigenome-wide association studies have also been conducted to explore the role of DNA methylation in DKD. This review aims to summarize the identified genetic and epigenetic risk factors for DKD.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Atrophy of the optic chiasm is associated with microvascular diabetic complications in type 1 diabetes

Aleksi Tarkkonen, Tor-Bjorn Claesson, Marika I. Eriksson, Carol Forsblom, Lena M. Thorn, Paula Summanen, Per-Henrik Groop, Jukka Putaala, Daniel Gordin, Juha Martola

Summary: Using magnetic resonance imaging, we found that the optic tracts of individuals with type 1 diabetes were smaller than those of healthy controls, suggesting that chronic hyperglycemia also damages the optic tract. This damage was associated with various metabolic measures as well as diabetic complications such as eye disease, kidney disease, neuropathy, and cerebral microbleeds.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Multidisciplinary Sciences

Genome-wide mRNA profiling in urinary extracellular vesicles reveals stress gene signature for diabetic kidney disease

Om Prakash Dwivedi, Karina Barreiro, Annemari Karajamaki, Erkka Valo, Anil K. Giri, Rashmi B. Prasad, Rishi Das Roy, Lena M. Thorn, Antti Rannikko, Harry Holthoefer, Kim M. Gooding, Steven Sourbron, Denis Delic, Maria F. Gomez, Per-Henrik Groop, Tiinamaija Tuomi, Carol Forsblom, Leif Groop, Maija Puhka

Summary: By genome-wide sequencing of 200 urinary extracellular vesicle (uEV) mRNA samples from clinical studies, we identified potential candidate biomarkers and mechanisms for studying diabetic kidney disease (DKD) in Type 1 diabetes (T1D), which were validated in both Type 1 and 2 diabetes. The sequencing results revealed over 10,000 mRNAs with similarity to the kidney transcriptome. Thirteen upregulated genes predominantly expressed in proximal tubules, correlated with hyperglycemia and involved in cellular/oxidative stress homeostasis were found in T1D DKD groups. We constructed a transcriptional stress score based on six of these genes (GPX3, NOX4, MSRB, MSRA, HRSP12, and CRYAB), which reflected long-term decline of kidney function and could identify individuals with early decline even in normoalbuminuric patients.

ISCIENCE (2023)

Review Cardiac & Cardiovascular Systems

Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table

Francesco Cosentino, Subodh Verma, Philip Ambery, Marianne Bach Treppendahl, Martin van Eickels, Stefan D. Anker, Michele Cecchini, Paola Fioretto, Per-Henrik Groop, David Hess, Kamlesh Khunti, Carolyn S. P. Lam, Isabelle Richard-Lordereau, Lars H. Lund, Paul McGreavy, Philip N. Newsome, Naveed Sattar, Scott Solomon, Franz Weidinger, Faiez Zannad, Andreas Zeiher

Summary: Metabolic comorbidities are common in cardiorenal disease and are associated with increased risk of poor outcomes of COVID-19 infection. Recognition and treatment of cardiometabolic diseases, as well as improving lifestyle and developing new biomarkers, are essential for prevention and management.

EUROPEAN HEART JOURNAL (2023)

Article Multidisciplinary Sciences

Medication profiling in women with type 1 diabetes highlights the importance of adequate, guideline-based treatment in low-risk groups

Raija Lithovius, Stefan Mutter, Erika B. Parente, Ville-Petteri Makinen, Erkka Valo, Valma Harjutsalo, Per-Henrik Groop

Summary: Effective treatment can prevent kidney complications in women with type 1 diabetes, but there may be underprescription in some cases. Data analysis of prescriptions and their relationship with kidney health can provide insights to optimize treatment.

SCIENTIFIC REPORTS (2023)

Article Endocrinology & Metabolism

Haptoglobin genotype and its relation to asymptomatic cerebral small-vessel disease in type 1 diabetes

M. I. Eriksson, A. Syreeni, N. Sandholm, E. H. Dahlstrom, D. Gordin, T. Tatlisumak, J. Putaala, Per-Henrik Groop, J. Martola, L. M. Thorn

Summary: This study aimed to evaluate the association between haptoglobin genotype and cerebral small-vessel disease (SVD). The results showed no significant association between haptoglobin genotype and SVD.

ACTA DIABETOLOGICA (2023)

No Data Available